InSilico Medicine (HKG:3696) said it was due to join the Hang Seng Composite Index on March 9, according to a Hong Kong bourse filing Friday.
The AI-driven drug discovery and development company listed on the Hong Kong bourse in December last year.
InSilico Medicine (HKG:3696) said it was due to join the Hang Seng Composite Index on March 9, according to a Hong Kong bourse filing Friday.
The AI-driven drug discovery and development company listed on the Hong Kong bourse in December last year.
Comments